Showing 8 of 8 recruiting trials for “atypical-hemolytic-uremic-syndrome-with-complement-gene-abnormality”
Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS
The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Multicenter, Observational, Retrospective Cohort Study in Egypt
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
👨⚕️ Marina Noris, PhD, Istituto Di Ricerche Farmacologiche Mario Negri📍 1 site📅 Started Feb 2024View details ↗
Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy
RecruitingNCT04745195 ↗
Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
👨⚕️ Pieter van Paassen, MD, PhD, Maastricht University Medical Center📍 1 site📅 Started Aug 2021View details ↗
RecruitingNCT01522183 ↗
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →